Tuesday, January 19, 2021

 Facility Licenses

A & G Pharmacy, PHY 52407, Administrative Case AC 6778
Winnetka, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered.
Decision effective 12/9/2020.

Alamo Pharmacy, PHY 51901, Administrative Case AC 6610
Simi Valley, CA
Through a disciplinary action of the Board, the license is revoked, the revocation stayed, and the license is placed on probation for five years subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

Colorado Pharmacy, PHY 52413, Administrative Case AC 6562
Los Angeles, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered.
Decision effective 12/9/2020.

CVS Pharmacy #3079, PHY 49549, Administrative Case AC 6734
Riverbank, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

CVS Pharmacy #9919, PHY 49371, Administrative Case AC 6741
Turlock, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

CVS Pharmacy #09884, PHY 49751, Administrative Case AC 6742
Modesto, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

CVS Pharmacy #2994, PHY 50132, Administrative Case AC 6743
Turlock, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

CVS Pharmacy #1467, PHY 49075, Administrative Case AC 6744
Modesto, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

CVS Pharmacy #17183, PHY 54149, Administrative Case AC 6745
Riverbank, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

CVS Pharmacy #16082, PHY 54223, Administrative Case AC 6746
Modesto, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

E R Pharmacy Rx, PHY 50257, Administrative Case AC 6831
Northridge, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered.
Decision effective 12/9/2020.

Fruitvale Avenue Pharmacy, PHY 53737, Administrative Case AC 6243
Oakland, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered.
Decision effective 12/9/2020.

Hawthorne Professional Pharmacy, PHY 38184, Administrative Case AC 6700
Hawthorne, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered. The effective date shall be stayed until April 8, 2021.
Decision effective 12/9/2020.

Horton & Converse Pharmacy, PHY 19454, Administrative Case AC 6609
Santa Monica, CA   
Through a disciplinary action of the Board, the license is voluntarily surrendered. 
Decision effective 10/8/2020.

Lockeford Drug, PHY 39960, Administrative Case AC 6781
Lockeford, CA
Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.
Decision effective 11/4/2020.

Molino Pharmacy, PHY 54954, Administrative Case AC 6667
Long Beach, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered.
Decision effective 12/23/2020.

Omnicare of Northern California, PHY 54230, Administrative Case AC 6753
Lodi, CA
Through a disciplinary action of the Board, the license is revoked, the revocation stayed, and the license is placed on probation for three years subject to the terms and conditions in the decision.
Decision effective 12/9/2020.

Payless Pharmacy, PHY 50705, Administrative Case AC 7000
Rosemead, CA
Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.
Decision effective 12/9/2020.

Pharmerica, PHY 55902, Administrative Case AC 6791
Union City, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 12/9/2020.

Pharmerica, PHY 55912, Administrative Case AC 6791
Sacramento, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 12/9/2020.

Pharmco Drugs, PHY 51829, Administrative Case AC 6872
Norco, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

Raley’s Pharmacy #336, PHY 53518, Administrative Case AC 6615
Brentwood, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/25/2020.

San Ysidro Pharmacy, Inc., PHY 46711, Administrative Case AC 5737
Santa Barbara, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered. The effective date shall be stayed until April 8, 2021, at which time the pharmacy shall be sold or closed.    
Decision effective 12/9/2020.

Star Pharmacy, PHY 57459, Administrative Case AC 6555
Van Nuys, CA
Through a disciplinary action of the Board, the license is publicly reproved and subject to the terms and conditions in the decision.
Decision effective 11/4/2020.

Tustin Community Pharmacy, PHY 30023, Administrative Case AC 6160
Tustin, CA   
Through a disciplinary action of the Board, the license is voluntarily surrendered. 
Decision effective 10/8/2020.

West Marin Pharmacy Inc, PHY 48531, Administrative Case AC 6801
Point Reyes Station, CA
Through a disciplinary action of the Board, the license is revoked, the revocation stayed, and the license is placed on probation for three years subject to the terms and conditions in the decision.
Decision effective 12/9/2020.

 Facility Licenses

Alixarx, PHY 51693, Administrative Case AC 6995
Fresno, CA
Accusation Filed 11/4/2020; Case pending.

Alixarx, LSC 99953 51693, Administrative Case AC 6995
Fresno, CA
Accusation Filed 11/4/2020; Case pending.

Edge Pharma LLC, NSF 132, Administrative Case AC 7047
Colchester, CA
Accusation Filed 11/12/2020; Case pending.

McKesson Drug Company, WLS 3076, Administrative Case AC 6850
Santa Fe Springs, CA
First Amended Accusation Filed 11/16/2020; Case pending.

OC Wellness and Specialty Pharmacy, PHY 55826, Administrative Case AC 6979
Orange, CA
Accusation Filed 11/23/2020; Case pending.

Omega Care Pharmacy, PHY 53936, Administrative Case AC 7004
Sherman Oaks, CA
Accusation Filed 11/23/2020; Case pending.

Santa Monica Medical Plaza Pharmacy, PHY 51669, Administrative Case AC 6865
Santa Monica, CA
Accusation Filed 11/23/2020; Case pending.

Skilled Nursing Pharmacy, PHY 49974, Administrative Case AC 6975
Hayward, CA
Accusation Filed 11/23/2020; Case pending.

Skilled Nursing Pharmacy, LSC 99561, Administrative Case AC 6975
Hayward, CA
Accusation Filed 11/23/2020; Case pending.

Tower Pharmacy, PHY 53607, Administrative Case AC 7035
Burbank, CA
Accusation Filed 11/16/2020; Case pending.

University of California Irvine Medical Center, HPE 49819, Administrative Case AC 6997         
Orange, CA
Accusation Filed 11/16/2020; Case pending.

University of California Irvine Medical Center, LSE 100230, Administrative Case AC 6997         
Orange, CA
Accusation Filed 11/16/2020; Case pending.

 

Application for Veterinarian Authority to Dispense Drugs

2 days ago — Nevada State Board of Pharmacy. 985 Damonte Ranch Parkway, Suite 206. Reno, NV 89521. If your dispensing address changes or you add additional 

Streamlining animal biotech rules unlikely as FDA rejects USDA proposal to take over regulation, citing ‘potential health repercussions’

Streamlining animal biotech rules unlikely as FDA rejects USDA proposal to take over regulation, citing ‘potential health repercussions’
Department of Justice
Office of Public Affairs

FOR IMMEDIATE RELEASE
Friday, January 15, 2021

Federal Court Restrains Toledo Pharmacy and Two Pharmacists From Dispensing Opioids or Other Controlled Substances

A federal court in Ohio issued a temporary restraining order enjoining a Toledo, Ohio, pharmacy and two of its pharmacists from dispensing opioids and other controlled substances, the Department of Justice announced today.

In a civil complaint filed Jan. 6, 2021, and unsealed Jan. 14, 2021, in the Northern District of Ohio, the United States alleges that Shaffer Pharmacy, its pharmacist owner Thomas Tadsen, and pharmacist Wilson Bunton repeatedly dispensed opioids and other controlled substances in violation of the Controlled Substances Act. The complaint alleges that over a period of several years, the defendants dispensed highly addictive and highly abused prescription opioids while ignoring “red flags” — that is, obvious indications of drug diversion and drug-seeking behavior. U.S. District Judge Jack Zouhary granted the government’s request for a temporary restraining order, which was filed along with the complaint.

“Federal law requires pharmacists to ensure that the controlled substance prescriptions they fill are medically legitimate,” said Acting Assistant Attorney General Jennifer B. Dickey of the Justice Department's Civil Division. “The Department of Justice will continue to work with DEA and our law enforcement partners to combat the opioid crisis by holding accountable pharmacies that abandon their obligations.”

“The illegal prescribing or dispensing of narcotics by medical personnel only serves to further worsen the opioid epidemic in northern Ohio and increase the number of overdose deaths in our community,” said Acting U.S. Attorney Bridget M. Brennan for the Northern District of Ohio. “Allegations of prescription misuse continue to be a priority for this office, and offenders should expect significant consequences.”

“Dispensing controlled substances is a privilege that requires abiding by the law,” said Drug Enforcement Administration (DEA) Special Agent in Charge Keith Martin. “DEA is committed to ensuring that those who have pledged to follow our nation’s drug laws are living up to that responsibility.”

“We continue to face an uphill battle against drug abuse and addiction, and it is unthinkable that a licensed provider would contribute to this growing epidemic,” said Special Agent in Charge Eric B. Smith of the FBI, Cleveland Division. “Restraining the ability of these defendants to continue filling prescriptions without medical necessity is a significant step. The FBI will continue efforts to identify and hold accountable any medical professional that violates their legal obligation to do no harm when they engage in criminal misconduct."

The complaint alleges that the defendants failed to take steps required to resolve red flags and ensure the legitimacy of prescriptions before filling them. According to court documents, the prescriptions dispensed by the defendants often involved highly abused opioid painkillers such as oxycodone, hydrocodone, oxymorphone, buprenorphine, and fentanyl, often in dangerous combination with other prescription drugs such as benzodiazepines (i.e., sedatives indicated for the treatment of anxiety, such as Xanax), and muscle relaxants (e.g., carisoprodol, also known by its brand name, Soma). The complaint seeks civil penalties as well as a permanent injunction against the defendants.   

The claims made in the complaint are merely allegations that the United States must prove if the case proceeds to trial.

The United States is represented by Assistant U.S. Attorneys Patricia Fitzgerald and Angelita Cruz Bridges for the Northern District of Ohio, and Trial Attorneys Scott Dahlquist and Maryann McGuire of the Justice Department’s Consumer Protection Branch. This investigation is being conducted by the DEA, FBI, U.S. Department of Health and Human Services Office of Inspector General, the State of Ohio Board of Pharmacy, the Ohio Bureau of Workers’ Compensation, and the Ohio Attorney General’s Medicaid Fraud Control Unit.

Topic(s): 
Consumer Protection
Opioids
Component(s): 
Press Release Number: 
21-60

Industry 4.0; Strengthening US Public Health Infrastructure The FDA moves to leverage Industry 4.0 to help strengthen the nation’s public health infrastructure Laura V. Garcia |Jan 17

https://www.manufacturingglobal.com/smart-manufacturing/industry-40-strengthening-us-public-health-infrastructure